Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship
- PMID: 22759550
- PMCID: PMC4370272
- DOI: 10.1086/666642
Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship
Abstract
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are rapidly emerging worldwide. Control group selection is critically important when analyzing predictors of antimicrobial resistance. Focusing on modifiable risk factors can optimize prevention and resource expenditures. To identify specific predictors of CRE, patients with CRE were compared with 3 control groups: (1) patients with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, (2) patients with non-ESBL-containing Enterobacteriaceae, and (3) uninfected controls.
Design: Matched multivariable analyses.
Patients and setting: Patients possessing CRE that were isolated at Detroit Medical Center from September 1, 2008, to August 31, 2009.
Methods: Patients were matched (1∶1 ratio) to the 3 sets of controls. Matching parameters included (1) bacteria type, (2) hospital/facility, (3) unit/clinic, (4) calendar year, and (5) time at risk (ie, from admission to culture). Matched multivariable analyses were conducted between uninfected controls and patients with CRE, ESBL, and non-ESBL Enterobacteriaceae. Models were also designed comparing patients with CRE to patients with ESBL, patients with non-ESBL Enterobacteriaceae, and all 3 non-CRE groups combined.
Results: Ninety-one unique patients with CRE were identified, and 6 matched models were constructed. Recent (less than 3 months) exposure to antibiotics was the only parameter that was consistently associated with CRE, regardless of the group to which CRE was compared, and was not independently associated with isolation of ESBL or non-ESBL Enterobacteriaceae.
Conclusions: Exposure to antibiotics within 3 months was an independent predictor that characterized patients with CRE isolation. As a result, antimicrobial stewardship efforts need to become a major focus of preventive interventions. Regulatory focus regarding appropriate antimicrobial use might decrease the detrimental effects of antibiotic misuse and spread of CRE.
Conflict of interest statement
Similar articles
-
Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis.Am J Infect Control. 2014 Jun;42(6):612-20. doi: 10.1016/j.ajic.2014.02.013. Am J Infect Control. 2014. PMID: 24837111
-
Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?Clin Microbiol Infect. 2013 May;19(5):451-6. doi: 10.1111/j.1469-0691.2012.03888.x. Epub 2012 May 7. Clin Microbiol Infect. 2013. PMID: 22563800
-
Risk Factors for Infections Caused by Extended-spectrum Beta-Lactamase Producing and Carbapenem-resistant Enterobacterales in Pediatric Critical Care Settings: A Case-control Study.Pediatr Infect Dis J. 2025 May 1;44(5):422-427. doi: 10.1097/INF.0000000000004650. Epub 2024 Nov 22. Pediatr Infect Dis J. 2025. PMID: 40215199
-
Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.Expert Rev Anti Infect Ther. 2016 Aug;14(8):705-17. doi: 10.1080/14787210.2016.1206815. Epub 2016 Jul 11. Expert Rev Anti Infect Ther. 2016. PMID: 27348447 Review.
-
Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis.Sci Rep. 2024 Oct 17;14(1):24349. doi: 10.1038/s41598-024-75791-6. Sci Rep. 2024. PMID: 39420082 Free PMC article.
Cited by
-
Internal Medicine Resident Perspectives Regarding Broad-Spectrum Antibiotic Usage.Open Forum Infect Dis. 2017 Apr 4;4(2):ofx060. doi: 10.1093/ofid/ofx060. eCollection 2017 Spring. Open Forum Infect Dis. 2017. PMID: 28534035 Free PMC article.
-
A "resistance calculator": Simple stewardship intervention for refining empiric practices of antimicrobials in acute-care hospitals.Infect Control Hosp Epidemiol. 2021 Sep;42(9):1082-1089. doi: 10.1017/ice.2020.1372. Epub 2021 Mar 19. Infect Control Hosp Epidemiol. 2021. PMID: 33736724 Free PMC article.
-
Case-case-control study of risk factors for carbapenem-resistant Enterobacterales infections among hospitalized patients.Antimicrob Steward Healthc Epidemiol. 2022 Jul 14;2(1):e118. doi: 10.1017/ash.2022.244. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36483348 Free PMC article.
-
Point Prevalence Survey of Antimicrobial Use in Four Tertiary Care Hospitals in Mexico.Infect Drug Resist. 2021 Nov 2;14:4553-4566. doi: 10.2147/IDR.S327721. eCollection 2021. Infect Drug Resist. 2021. PMID: 34754203 Free PMC article.
-
Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE.Antimicrob Resist Infect Control. 2019 May 20;8:78. doi: 10.1186/s13756-019-0529-z. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31139361 Free PMC article.
References
-
- Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 2011;52(7):848–855. - PubMed
-
- Munoz-Price LS, Hayden MK, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase–producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010;31(4):341–347. - PubMed
-
- Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2–producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2009;50(3):364–373. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials